Document is current
Any future updates will be listed below
-
Authors
An, Ran
Xu, Xiaolin
Wang, Yue
Ding, Jiayi
Li, Boyu
Yang, Fan
Liu, Ming
Tian, Linli
-
Funding
Funding for this research was provided by:
Chinese Cardiovascular Association-Natural lipid-lowering drugs fund (2023-CCA-NLD-796)
National Natural Science Foundation of China (82173209, 82273332)
- License Information
-
More Information
Article History
Received: 10 November 2024
Accepted: 16 April 2025
First Online: 23 April 2025
Declarations
:
: The authors declare no competing interests.
: This study was approved by the ethics committee of Harbin Medical University (approval No. YJSKY2022-057). We certify that the study was performed in accordance with the 1964 declaration of HELSINKI and later amendments.
: Written informed consent was obtained from all the participants prior to the enrollment of this study.
